Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial
-
By
-
Ignacio Melero
-
Bernhard Reis
-
Corinne Rusterholz
-
Alexandra Epp
-
Nicole A. Kratochwil
-
Chun Wu
-
Michael Hettich
-
Georgios Kazantzidis
-
Natascha Rieder
-
Petra C. Schwalie
-
Solveig Badillo
-
Nadine Kumpesa
-
Andreas Thommen
-
Danielle J. Vugts
-
Victor Moreno
-
Julia Lostes Bardaji
-
Eduardo Castanon Alvarez
-
Carlos E. de Andrea
-
Iben Spanggaard
-
Dae Ho Lee
-
James Spicer
-
Fiona Thistlethwaite
-
Do-Youn Oh
-
Antoine Hollebecque
-
Olivera Cirovic
-
Stefan N. Symeonides
-
May 1, 2026
-
0 min
